25 XP   0   0   10

Pharmaniaga Bhd
Buy, Hold or Sell?

Let's analyse Pharmaniaga Bhd together

PenkeI guess you are interested in Pharmaniaga Bhd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pharmaniaga Bhd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pharmaniaga Bhd

I send you an email if I find something interesting about Pharmaniaga Bhd.

Quick analysis of Pharmaniaga Bhd (30 sec.)










What can you expect buying and holding a share of Pharmaniaga Bhd? (30 sec.)

How much money do you get?

How much money do you get?
RM0.03
When do you have the money?
1 year
How often do you get paid?
63.6%

What is your share worth?

Current worth
RM-0.10
Expected worth in 1 year
RM-0.47
How sure are you?
77.3%

+ What do you gain per year?

Total Gains per Share
RM-0.26
Return On Investment
-58.4%

For what price can you sell your share?

Current Price per Share
RM0.44
Expected price per share
RM0.43 - RM0.51426542056075
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Pharmaniaga Bhd (5 min.)




Live pricePrice per Share (EOD)

RM0.44

Intrinsic Value Per Share

RM2.73 - RM3.32

Total Value Per Share

RM2.63 - RM3.22

2. Growth of Pharmaniaga Bhd (5 min.)




Is Pharmaniaga Bhd growing?

Current yearPrevious yearGrowGrow %
How rich?-$29.4m$88.7m-$95m-1,505.5%

How much money is Pharmaniaga Bhd making?

Current yearPrevious yearGrowGrow %
Making money-$33.6m$8.7m-$42.4m-125.9%
Net Profit Margin-18.3%4.3%--

How much money comes from the company's main activities?

3. Financial Health of Pharmaniaga Bhd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Pharmaniaga Bhd? (5 min.)

Welcome investor! Pharmaniaga Bhd's management wants to use your money to grow the business. In return you get a share of Pharmaniaga Bhd.

What can you expect buying and holding a share of Pharmaniaga Bhd?

First you should know what it really means to hold a share of Pharmaniaga Bhd. And how you can make/lose money.

Speculation

The Price per Share of Pharmaniaga Bhd is RM0.44. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmaniaga Bhd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmaniaga Bhd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is RM-0.10. Based on the TTM, the Book Value Change Per Share is RM-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is RM0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is RM0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmaniaga Bhd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 RM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per ShareRM% of Price per Share
Usd Eps0.000.1%-0.02-5.3%0.011.4%0.00-1.0%0.00-0.7%
Usd Book Value Change Per Share0.000.2%-0.02-4.6%0.000.4%-0.01-1.3%0.00-0.2%
Usd Dividend Per Share0.000.3%0.011.5%0.011.3%0.000.9%0.000.7%
Usd Total Gains Per Share0.000.4%-0.01-3.1%0.011.7%0.00-0.4%0.000.5%
Usd Price Per Share0.08-0.09-0.16-0.42-0.60-
Price to Earnings Ratio67.98-32.00-78.97-194.70-183.67-
Price-to-Total Gains Ratio42.24-13.42-3.01-473.41-276.75-
Price to Book Ratio-3.86--2.02-2.54-6.64-8.47-
Price-to-Total Gains Ratio42.24-13.42-3.01-473.41-276.75-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.09394
Number of shares10645
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share-0.02-0.01
Usd Total Gains Per Share-0.010.00
Gains per Quarter (10645 shares)-145.98-17.54
Gains per Year (10645 shares)-583.91-70.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1275-859-594168-238-80
2549-1717-1178336-476-150
3824-2576-1762503-714-220
41099-3434-2346671-952-290
51373-4293-2930839-1190-360
61648-5152-35141007-1428-430
71923-6010-40981174-1666-500
82198-6869-46821342-1903-570
92472-7727-52661510-2141-640
102747-8586-58501678-2379-710

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%15.03.00.083.3%19.03.00.086.4%19.03.00.086.4%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%10.08.00.055.6%12.010.00.054.5%12.010.00.054.5%
Dividend per Share4.00.00.0100.0%10.00.02.083.3%14.00.04.077.8%14.00.08.063.6%14.00.08.063.6%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%15.03.00.083.3%17.05.00.077.3%17.05.00.077.3%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Pharmaniaga Bhd

About Pharmaniaga Bhd

Pharmaniaga Berhad, an investment holding company, operates as an integrated pharmaceutical company in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products. The company also manufactures and sells generic drugs; over-the-counter medicines; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and operates community pharmacies under the RoyalePharma brand name. The company was founded in 1994 and is based in Shah Alam, Malaysia. Pharmaniaga Berhad is a subsidiary of Boustead Holdings Berhad.

Fundamental data was last updated by Penke on 2023-09-17 01:22:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Pharmaniaga Bhd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pharmaniaga Bhd earns for each RM1 of revenue.

  • Above 10% is considered healthy but always compare Pharmaniaga Bhd to the Medical Distribution industry mean.
  • A Net Profit Margin of 0.2% means that RM0.00 for each RM1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pharmaniaga Bhd:

  • The MRQ is 0.2%. The company is not making a profit/loss.
  • The TTM is -18.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ0.2%TTM-18.3%+18.5%
TTM-18.3%YOY4.3%-22.6%
TTM-18.3%5Y-3.8%-14.5%
5Y-3.8%10Y-2.6%-1.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%2.2%-2.0%
TTM-18.3%2.2%-20.5%
YOY4.3%2.2%+2.1%
5Y-3.8%2.1%-5.9%
10Y-2.6%1.9%-4.5%
1.1.2. Return on Assets

Shows how efficient Pharmaniaga Bhd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharmaniaga Bhd to the Medical Distribution industry mean.
  • 0.1% Return on Assets means that Pharmaniaga Bhd generated RM0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pharmaniaga Bhd:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -8.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-8.7%+8.8%
TTM-8.7%YOY1.8%-10.5%
TTM-8.7%5Y-1.9%-6.8%
5Y-1.9%10Y-1.3%-0.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%0.9%-0.8%
TTM-8.7%0.9%-9.6%
YOY1.8%0.9%+0.9%
5Y-1.9%0.9%-2.8%
10Y-1.3%1.0%-2.3%
1.1.3. Return on Equity

Shows how efficient Pharmaniaga Bhd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharmaniaga Bhd to the Medical Distribution industry mean.
  • 0.0% Return on Equity means Pharmaniaga Bhd generated RM0.00 for each RM1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pharmaniaga Bhd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.5%-0.5%
TTM0.5%YOY9.6%-9.1%
TTM0.5%5Y0.6%-0.1%
5Y0.6%10Y0.5%+0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.8%-2.8%
TTM0.5%2.7%-2.2%
YOY9.6%2.3%+7.3%
5Y0.6%2.5%-1.9%
10Y0.5%2.5%-2.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Pharmaniaga Bhd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pharmaniaga Bhd is operating .

  • Measures how much profit Pharmaniaga Bhd makes for each RM1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharmaniaga Bhd to the Medical Distribution industry mean.
  • An Operating Margin of 0.0% means the company generated RM0.00  for each RM1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pharmaniaga Bhd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-1.1%+1.1%
5Y-1.1%10Y0.1%-1.2%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%-3.0%
TTM-1.5%-1.5%
YOY-3.6%-3.6%
5Y-1.1%3.1%-4.2%
10Y0.1%2.1%-2.0%
1.2.2. Operating Ratio

Measures how efficient Pharmaniaga Bhd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.86 means that the operating costs are RM1.86 for each RM1 in net sales.

Let's take a look of the Operating Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 1.861. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.045. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.861TTM2.045-0.184
TTM2.045YOY1.778+0.267
TTM2.0455Y1.815+0.231
5Y1.81510Y1.811+0.004
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8611.595+0.266
TTM2.0451.550+0.495
YOY1.7781.443+0.335
5Y1.8151.412+0.403
10Y1.8111.231+0.580
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Pharmaniaga Bhd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pharmaniaga Bhd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 0.68 means the company has RM0.68 in assets for each RM1 in short-term debts.

Let's take a look of the Current Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.685. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.772. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.685TTM0.772-0.087
TTM0.772YOY1.074-0.301
TTM0.7725Y0.868-0.096
5Y0.86810Y0.871-0.003
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6851.381-0.696
TTM0.7721.424-0.652
YOY1.0741.396-0.322
5Y0.8681.405-0.537
10Y0.8711.267-0.396
1.3.2. Quick Ratio

Measures if Pharmaniaga Bhd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharmaniaga Bhd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.32 means the company can pay off RM0.32 for each RM1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.323. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.279. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.323TTM0.279+0.044
TTM0.279YOY0.309-0.030
TTM0.2795Y0.326-0.048
5Y0.32610Y0.317+0.009
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3230.715-0.392
TTM0.2790.750-0.471
YOY0.3090.840-0.531
5Y0.3260.786-0.460
10Y0.3170.835-0.518
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Pharmaniaga Bhd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pharmaniaga Bhd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharmaniaga Bhd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 1.07 means that Pharmaniaga Bhd assets are financed with 106.7% credit (debt) and the remaining percentage (100% - 106.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 1.067. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.027. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.067TTM1.027+0.039
TTM1.027YOY0.825+0.202
TTM1.0275Y0.846+0.181
5Y0.84610Y0.807+0.040
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0670.612+0.455
TTM1.0270.612+0.415
YOY0.8250.617+0.208
5Y0.8460.617+0.229
10Y0.8070.591+0.216
1.4.2. Debt to Equity Ratio

Measures if Pharmaniaga Bhd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharmaniaga Bhd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 0.0% means that company has RM0.00 debt for each RM1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pharmaniaga Bhd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.301-1.301
TTM1.301YOY4.764-3.463
TTM1.3015Y3.453-2.152
5Y3.45310Y2.825+0.628
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.647-1.647
TTM1.3011.686-0.385
YOY4.7641.760+3.004
5Y3.4531.719+1.734
10Y2.8251.758+1.067
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Pharmaniaga Bhd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every RM1 in earnings Pharmaniaga Bhd generates.

  • Above 15 is considered overpriced but always compare Pharmaniaga Bhd to the Medical Distribution industry mean.
  • A PE ratio of 67.98 means the investor is paying RM67.98 for every RM1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pharmaniaga Bhd:

  • The EOD is 80.844. Based on the earnings, the company is expensive. -2
  • The MRQ is 67.983. Based on the earnings, the company is expensive. -2
  • The TTM is 31.998. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD80.844MRQ67.983+12.862
MRQ67.983TTM31.998+35.985
TTM31.998YOY78.974-46.976
TTM31.9985Y194.699-162.701
5Y194.69910Y183.671+11.028
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD80.84415.182+65.662
MRQ67.98318.476+49.507
TTM31.99814.747+17.251
YOY78.97418.795+60.179
5Y194.69915.661+179.038
10Y183.67115.854+167.817
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pharmaniaga Bhd:

  • The EOD is 1.652. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.389. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 4.917. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.652MRQ1.389+0.263
MRQ1.389TTM4.917-3.528
TTM4.917YOY-8.511+13.429
TTM4.9175Y-16.893+21.811
5Y-16.89310Y-13.822-3.071
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD1.6527.295-5.643
MRQ1.3898.708-7.319
TTM4.9179.670-4.753
YOY-8.5119.583-18.094
5Y-16.8934.175-21.068
10Y-13.8222.602-16.424
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pharmaniaga Bhd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of -3.86 means the investor is paying RM-3.86 for each RM1 in book value.

Let's take a look of the Price to Book Ratio trends of Pharmaniaga Bhd:

  • The EOD is -4.596. Based on the equity, the company is expensive. -2
  • The MRQ is -3.865. Based on the equity, the company is expensive. -2
  • The TTM is -2.024. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.596MRQ-3.865-0.731
MRQ-3.865TTM-2.024-1.841
TTM-2.024YOY2.544-4.568
TTM-2.0245Y6.636-8.659
5Y6.63610Y8.470-1.834
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD-4.5961.273-5.869
MRQ-3.8651.353-5.218
TTM-2.0241.409-3.433
YOY2.5441.382+1.162
5Y6.6361.535+5.101
10Y8.4702.223+6.247
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Pharmaniaga Bhd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.003-0.094+2938%0.008-60%-0.026+887%-0.004+231%
Book Value Per Share---0.096-0.021-79%0.288-133%0.215-145%0.246-139%
Current Ratio--0.6850.772-11%1.074-36%0.868-21%0.871-21%
Debt To Asset Ratio--1.0671.027+4%0.825+29%0.846+26%0.807+32%
Debt To Equity Ratio---1.301-100%4.764-100%3.453-100%2.825-100%
Dividend Per Share--0.0050.030-82%0.027-80%0.018-71%0.015-64%
Eps--0.001-0.109+8146%0.028-95%-0.021+1665%-0.015+1218%
Free Cash Flow Per Share--0.067-0.004+106%0.025+165%-0.018+127%-0.018+127%
Free Cash Flow To Equity Per Share--0.0280.063-56%0.108-74%0.074-62%0.074-62%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.315--------
Intrinsic Value_10Y_min--2.729--------
Intrinsic Value_1Y_max---0.006--------
Intrinsic Value_1Y_min---0.006--------
Intrinsic Value_3Y_max--0.241--------
Intrinsic Value_3Y_min--0.224--------
Intrinsic Value_5Y_max--0.797--------
Intrinsic Value_5Y_min--0.718--------
Market Cap634141178.880+16%533255082.240617927341.920-14%1053899402.400-49%2850432571.733-81%4019066252.509-87%
Net Profit Margin--0.002-0.183+8024%0.043-95%-0.038+1763%-0.026+1215%
Operating Margin----0%-0%-0.0110%0.001-100%
Operating Ratio--1.8612.045-9%1.778+5%1.815+3%1.811+3%
Pb Ratio-4.596-19%-3.865-2.024-48%2.544-252%6.636-158%8.470-146%
Pe Ratio80.844+16%67.98331.998+112%78.974-14%194.699-65%183.671-63%
Price Per Share0.440+16%0.3700.429-14%0.731-49%1.978-81%2.789-87%
Price To Free Cash Flow Ratio1.652+16%1.3894.917-72%-8.511+713%-16.893+1316%-13.822+1095%
Price To Total Gains Ratio50.229+16%42.23813.423+215%3.006+1305%473.405-91%276.746-85%
Quick Ratio--0.3230.279+16%0.309+4%0.326-1%0.317+2%
Return On Assets--0.001-0.087+9268%0.018-95%-0.019+2099%-0.013+1511%
Return On Equity---0.005-100%0.096-100%0.006-100%0.005-100%
Total Gains Per Share--0.009-0.064+833%0.036-75%-0.008+188%0.011-19%
Usd Book Value---29457022.000-6315383.375-79%88759956.250-133%66105151.000-145%75610714.455-139%
Usd Book Value Change Per Share--0.001-0.020+2938%0.002-60%-0.006+887%-0.001+231%
Usd Book Value Per Share---0.020-0.004-79%0.062-133%0.046-145%0.052-139%
Usd Dividend Per Share--0.0010.006-82%0.006-80%0.004-71%0.003-64%
Usd Eps--0.000-0.023+8146%0.006-95%-0.005+1665%-0.003+1218%
Usd Free Cash Flow--20491516.500-1198535.625+106%7721654.500+165%-4297695.694+121%-3516296.477+117%
Usd Free Cash Flow Per Share--0.014-0.001+106%0.005+165%-0.004+127%-0.004+127%
Usd Free Cash Flow To Equity Per Share--0.0060.013-56%0.023-74%0.016-62%0.016-62%
Usd Market Cap135389141.691+16%113849960.058131927487.500-14%225007522.412-49%608567354.065-81%858070644.911-87%
Usd Price Per Share0.094+16%0.0790.092-14%0.156-49%0.422-81%0.595-87%
Usd Profit--418673.500-33688378.500+8146%8741010.250-95%-6550749.333+1665%-4680385.818+1218%
Usd Revenue--181204709.000187697937.875-3%243799332.875-26%185039038.528-2%173483122.432+4%
Usd Total Gains Per Share--0.002-0.014+833%0.008-75%-0.002+188%0.002-19%
 EOD+5 -3MRQTTM+19 -15YOY+9 -255Y+16 -1810Y+16 -19

3.2. Fundamental Score

Let's check the fundamental score of Pharmaniaga Bhd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1580.844
Price to Book Ratio (EOD)Between0-1-4.596
Net Profit Margin (MRQ)Greater than00.002
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.323
Current Ratio (MRQ)Greater than10.685
Debt to Asset Ratio (MRQ)Less than11.067
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.001
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Pharmaniaga Bhd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.420
Ma 20Greater thanMa 500.458
Ma 50Greater thanMa 1000.429
Ma 100Greater thanMa 2000.398
OpenGreater thanClose0.445
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in MYR. All numbers in thousands.

Summary
Total Assets2,062,093
Total Liabilities2,200,065
Total Stockholder Equity-137,972
 As reported
Total Liabilities 2,200,065
Total Stockholder Equity+ -137,972
Total Assets = 2,062,093

Assets

Total Assets2,062,093
Total Current Assets1,295,878
Long-term Assets1,295,878
Total Current Assets
Cash And Cash Equivalents 27,774
Net Receivables 583,131
Inventory 672,991
Total Current Assets  (as reported)1,295,878
Total Current Assets  (calculated)1,283,896
+/- 11,982
Long-term Assets
Property Plant Equipment 576,349
Goodwill 77,577
Intangible Assets 86,571
Other Assets 25,718
Long-term Assets  (as reported)766,215
Long-term Assets  (calculated)766,215
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,892,458
Long-term Liabilities282,565
Total Stockholder Equity-137,972
Total Current Liabilities
Short-term Debt 668,892
Short Long Term Debt 914,059
Accounts payable 940,784
Total Current Liabilities  (as reported)1,892,458
Total Current Liabilities  (calculated)2,523,735
+/- 631,277
Long-term Liabilities
Long term Debt Total 222,933
Capital Lease Obligations 8,604
Long-term Liabilities  (as reported)282,565
Long-term Liabilities  (calculated)231,537
+/- 51,028
Total Stockholder Equity
Common Stock154,189
Retained Earnings -397,887
Capital Surplus 3,624
Other Stockholders Equity 3,290
Total Stockholder Equity (as reported)-137,972
Total Stockholder Equity (calculated)-236,784
+/- 98,812
Other
Capital Stock154,189
Cash and Short Term Investments 27,774
Common Stock Shares Outstanding 1,310,209
Liabilities and Stockholders Equity 2,062,093
Net Debt 1,106,406
Net Invested Capital 996,208
Net Working Capital -596,580



Balance Sheet

Currency in MYR. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312016-03-312015-12-312015-09-302015-06-30
> Total Assets 
1,427,000
1,474,000
1,496,000
1,574,000
1,905,136
1,917,879
1,944,461
1,592,302
1,699,415
1,813,208
1,765,665
1,580,157
1,905,658
2,547,892
2,382,710
2,257,863
2,467,583
2,440,944
2,551,246
1,818,761
2,121,509
2,062,093
2,062,0932,121,5091,818,7612,551,2462,440,9442,467,5832,257,8632,382,7102,547,8921,905,6581,580,1571,765,6651,813,2081,699,4151,592,3021,944,4611,917,8791,905,1361,574,0001,496,0001,474,0001,427,000
   > Total Current Assets 
782,000
792,000
769,000
831,000
1,048,790
1,062,547
1,084,253
933,711
1,054,222
1,161,047
1,125,903
926,244
1,247,948
1,882,528
1,720,692
1,621,194
1,828,190
1,776,254
1,866,070
1,188,119
1,356,900
1,295,878
1,295,8781,356,9001,188,1191,866,0701,776,2541,828,1901,621,1941,720,6921,882,5281,247,948926,2441,125,9031,161,0471,054,222933,7111,084,2531,062,5471,048,790831,000769,000792,000782,000
       Cash And Cash Equivalents 
16,000
18,000
23,000
28,000
0
0
39,423
29,587
34,230
32,718
36,540
40,696
62,781
65,501
53,776
52,359
136,542
39,887
32,795
52,849
56,621
27,774
27,77456,62152,84932,79539,887136,54252,35953,77665,50162,78140,69636,54032,71834,23029,58739,4230028,00023,00018,00016,000
       Short-term Investments 
0
0
3,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000003,00000
       Net Receivables 
249,000
281,000
182,000
285,000
426,312
414,428
465,548
204,100
506,766
485,112
457,346
237,411
544,839
822,720
522,672
297,722
456,266
455,263
509,203
261,751
552,362
583,131
583,131552,362261,751509,203455,263456,266297,722522,672822,720544,839237,411457,346485,112506,766204,100465,548414,428426,312285,000182,000281,000249,000
       Inventory 
517,000
492,000
540,000
518,000
558,891
589,539
562,436
617,909
511,961
640,745
629,370
586,713
630,411
984,078
1,135,896
1,264,369
1,225,068
1,267,833
1,304,113
767,263
732,513
672,991
672,991732,513767,2631,304,1131,267,8331,225,0681,264,3691,135,896984,078630,411586,713629,370640,745511,961617,909562,436589,539558,891518,000540,000492,000517,000
   > Long-term Assets 
0
0
0
0
0
0
860,208
658,591
645,193
652,161
639,762
653,913
657,710
665,364
662,018
636,669
639,393
664,690
685,176
630,642
764,609
766,215
766,215764,609630,642685,176664,690639,393636,669662,018665,364657,710653,913639,762652,161645,193658,591860,208000000
       Property Plant Equipment 
0
0
0
0
421,134
419,563
417,694
410,110
403,265
402,199
395,063
398,471
399,704
407,077
399,810
395,590
397,289
421,131
434,495
443,034
576,239
576,349
576,349576,239443,034434,495421,131397,289395,590399,810407,077399,704398,471395,063402,199403,265410,110417,694419,563421,1340000
       Goodwill 
127,000
130,000
133,000
130,000
131,292
132,410
132,783
132,783
127,004
133,715
129,800
131,105
130,919
131,105
133,601
129,475
129,661
130,221
131,712
77,341
77,447
77,577
77,57777,44777,341131,712130,221129,661129,475133,601131,105130,919131,105129,800133,715127,004132,783132,783132,410131,292130,000133,000130,000127,000
       Intangible Assets 
0
0
0
0
265,824
266,057
269,596
67,559
66,808
72,193
71,598
73,932
76,083
77,737
72,924
78,538
80,258
81,257
85,292
83,220
84,340
86,571
86,57184,34083,22085,29281,25780,25878,53872,92477,73776,08373,93271,59872,19366,80867,559269,596266,057265,8240000
       Other Assets 
0
0
0
0
38,096
37,302
40,135
48,139
48,116
44,054
43,301
50,405
51,004
49,445
55,683
33,066
32,185
32,081
33,677
27,047
26,583
25,718
25,71826,58327,04733,67732,08132,18533,06655,68349,44551,00450,40543,30144,05448,11648,13940,13537,30238,0960000
> Total Liabilities 
873,000
911,000
936,000
1,033,000
1,376,163
1,397,104
1,409,292
1,254,451
1,349,440
1,455,186
1,420,106
1,242,629
1,548,935
2,189,828
1,990,870
1,807,401
2,053,439
2,034,440
2,140,085
2,067,503
2,264,277
2,200,065
2,200,0652,264,2772,067,5032,140,0852,034,4402,053,4391,807,4011,990,8702,189,8281,548,9351,242,6291,420,1061,455,1861,349,4401,254,4511,409,2921,397,1041,376,1631,033,000936,000911,000873,000
   > Total Current Liabilities 
839,000
874,000
894,000
989,000
1,272,960
1,292,472
1,323,445
1,200,581
1,300,295
1,402,510
1,370,804
1,193,819
1,497,322
2,023,244
1,636,639
1,467,763
1,698,220
1,672,854
1,766,156
1,820,228
1,953,425
1,892,458
1,892,4581,953,4251,820,2281,766,1561,672,8541,698,2201,467,7631,636,6392,023,2441,497,3221,193,8191,370,8041,402,5101,300,2951,200,5811,323,4451,292,4721,272,960989,000894,000874,000839,000
       Short-term Debt 
430,000
505,000
400,000
598,000
0
0
0
564,616
640,025
676,631
728,847
668,837
534,515
811,560
484,942
543,979
525,048
610,745
608,794
681,300
756,790
668,892
668,892756,790681,300608,794610,745525,048543,979484,942811,560534,515668,837728,847676,631640,025564,616000598,000400,000505,000430,000
       Short Long Term Debt 
430,000
505,000
400,000
598,000
0
0
709,346
564,616
640,025
676,631
728,847
668,837
789,515
1,007,560
516,242
569,679
653,648
781,353
776,502
967,753
1,029,857
914,059
914,0591,029,857967,753776,502781,353653,648569,679516,2421,007,560789,515668,837728,847676,631640,025564,616709,34600598,000400,000505,000430,000
       Accounts payable 
396,000
359,000
437,000
384,000
0
0
594,632
548,994
650,174
716,215
625,045
441,562
697,472
986,746
1,072,010
677,633
945,339
847,735
947,114
693,442
881,095
940,784
940,784881,095693,442947,114847,735945,339677,6331,072,010986,746697,472441,562625,045716,215650,174548,994594,63200384,000437,000359,000396,000
       Other Current Liabilities 
14,000
10,000
44,000
8,000
0
0
341
341
341
341
0
0
0
0
0
0
0
0
0
0
0
0
000000000000341341341341008,00044,00010,00014,000
   > Long-term Liabilities 
0
0
0
0
0
0
85,847
34,795
31,801
33,315
31,460
31,373
32,267
146,880
333,304
319,659
334,050
340,134
351,319
225,889
287,274
282,565
282,565287,274225,889351,319340,134334,050319,659333,304146,88032,26731,37331,46033,31531,80134,79585,847000000
       Long term Debt Total 
0
0
0
0
8,299
8,629
5,281
2,441
3,355
0
2,380
927
695
116,933
294,420
285,611
299,839
303,529
313,857
194,665
225,662
222,933
222,933225,662194,665313,857303,529299,839285,611294,420116,9336959272,38003,3552,4415,2818,6298,2990000
       Capital Lease Obligations 
0
0
0
0
0
0
14,844
4,263
5,458
4,856
4,446
2,913
2,395
2,854
2,417
2,192
1,943
7,288
11,537
10,673
10,139
8,604
8,60410,13910,67311,5377,2881,9432,1922,4172,8542,3952,9134,4464,8565,4584,26314,844000000
> Total Stockholder Equity
0
0
0
0
528,973
520,775
515,953
337,851
349,975
358,022
345,559
337,528
356,723
358,064
391,840
450,462
414,144
406,504
411,161
-248,742
-142,768
-137,972
-137,972-142,768-248,742411,161406,504414,144450,462391,840358,064356,723337,528345,559358,022349,975337,851515,953520,775528,9730000
   Common Stock
141,000
141,000
141,000
141,000
149,401
151,879
151,879
151,879
151,879
153,339
153,339
153,339
153,339
154,051
154,051
154,051
154,051
154,051
154,051
154,189
154,189
154,189
154,189154,189154,189154,051154,051154,051154,051154,051154,051153,339153,339153,339153,339151,879151,879151,879151,879149,401141,000141,000141,000141,000
   Retained Earnings Total Equity0000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000
   Capital Surplus 
0
0
0
0
8,657
7,543
6,693
7,191
7,689
3,333
3,440
1,996
2,104
0
403
1,670
2,672
3,674
4,008
3,624
3,624
3,624
3,6243,6243,6244,0083,6742,6721,67040302,1041,9963,4403,3337,6897,1916,6937,5438,6570000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
0
414
2,541
3,264
3,289
-7,484
6,020
-1,450
452
-1,277
-954
2,233
1,016
1,460
2,576
5,126
-2,281
235
3,290
3,290235-2,2815,1262,5761,4601,0162,233-954-1,277452-1,4506,020-7,4843,2893,2642,5414140000



Balance Sheet

Currency in MYR. All numbers in thousands.




Cash Flow

Currency in MYR. All numbers in thousands.




Income Statement

Currency in MYR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue3,510,677
Cost of Revenue-3,690,523
Gross Profit-179,846-179,846
 
Operating Income (+$)
Gross Profit-179,846
Operating Expense-4,004,908
Operating Income-541,718-4,184,754
 
Operating Expense (+$)
Research Development-
Selling General Administrative314,716
Selling And Marketing Expenses-
Operating Expense4,004,908314,716
 
Net Interest Income (+$)
Interest Income-39,128
Interest Expense--42
Other Finance Cost-42
Net Interest Income-39,128
 
Pretax Income (+$)
Operating Income-541,718
Net Interest Income-39,128
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-580,846-541,718
EBIT - interestExpense = 42
-607,317
-607,359
Interest Expense-42
Earnings Before Interest and Taxes (EBIT)--580,888
Earnings Before Interest and Taxes (EBITDA)-540,808
 
After tax Income (+$)
Income Before Tax-580,846
Tax Provision-24,204
Net Income From Continuing Ops-605,050-605,050
Net Income-607,317
Net Income Applicable To Common Shares-607,317
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-39,128
 

Technical Analysis of Pharmaniaga Bhd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharmaniaga Bhd. The general trend of Pharmaniaga Bhd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharmaniaga Bhd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pharmaniaga Bhd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.49941067961165 < 0.51 < 0.51426542056075.

The bearish price targets are: 0.44 > 0.435 > 0.43.

Tweet this
Pharmaniaga Bhd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pharmaniaga Bhd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pharmaniaga Bhd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pharmaniaga Bhd. The current macd is 0.00489119.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmaniaga Bhd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pharmaniaga Bhd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pharmaniaga Bhd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pharmaniaga Bhd Daily Moving Average Convergence/Divergence (MACD) ChartPharmaniaga Bhd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pharmaniaga Bhd. The current adx is 26.54.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pharmaniaga Bhd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Pharmaniaga Bhd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pharmaniaga Bhd. The current sar is 0.49945004.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pharmaniaga Bhd Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pharmaniaga Bhd. The current rsi is 48.42. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Pharmaniaga Bhd Daily Relative Strength Index (RSI) ChartPharmaniaga Bhd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pharmaniaga Bhd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmaniaga Bhd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pharmaniaga Bhd Daily Stochastic Oscillator ChartPharmaniaga Bhd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pharmaniaga Bhd. The current cci is -80.92056422.

Pharmaniaga Bhd Daily Commodity Channel Index (CCI) ChartPharmaniaga Bhd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pharmaniaga Bhd. The current cmo is -11.91613001.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pharmaniaga Bhd Daily Chande Momentum Oscillator (CMO) ChartPharmaniaga Bhd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pharmaniaga Bhd. The current willr is -85.71428571.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Pharmaniaga Bhd Daily Williams %R ChartPharmaniaga Bhd Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pharmaniaga Bhd.

Pharmaniaga Bhd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pharmaniaga Bhd. The current atr is 0.01871253.

Pharmaniaga Bhd Daily Average True Range (ATR) ChartPharmaniaga Bhd Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pharmaniaga Bhd. The current obv is 78,436,998.

Pharmaniaga Bhd Daily On-Balance Volume (OBV) ChartPharmaniaga Bhd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pharmaniaga Bhd. The current mfi is 44.45.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pharmaniaga Bhd Daily Money Flow Index (MFI) ChartPharmaniaga Bhd Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pharmaniaga Bhd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-05-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-05-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-05-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-05-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-05-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-05-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-05-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-05-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-05-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-05-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-06-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-06-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-06-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-06-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-06-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-06-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-06-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-06-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-07-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-07-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-07-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-07-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-07-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-07-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-07-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-07-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-07-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-07-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-07-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-07-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-08-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-08-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-08-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-08-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-09-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-09-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-09-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-09-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-09-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-09-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-09-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Pharmaniaga Bhd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pharmaniaga Bhd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.420
Ma 20Greater thanMa 500.458
Ma 50Greater thanMa 1000.429
Ma 100Greater thanMa 2000.398
OpenGreater thanClose0.445
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pharmaniaga Bhd with someone you think should read this too:
  • Are you bullish or bearish on Pharmaniaga Bhd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharmaniaga Bhd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pharmaniaga Bhd

I send you an email if I find something interesting about Pharmaniaga Bhd.


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about Pharmaniaga Bhd.

Receive notifications about Pharmaniaga Bhd in your mailbox!